/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES/
WINNIPEG, Feb. 20, 2018 /CNW/ - Delta 9 Cannabis Inc. (TSXV:NINE) ("Delta 9" or the "Company") today announced that it has granted, effective today, an aggregate of 376,500 stock options (each an "Option") to certain directors, officers, employees and consultants of the Company in accordance with the Company's current stock option plan. Each Option is exercisable into one common share (a "Share") of the Company at a price of $2.30 per Share for a period of five years from the date of grant, being today. The Options will vest over twelve months, with one third vesting on the date that is four months from the date hereof, one third vesting on the date that is eight months from the date hereof and the remaining one third vesting on the date that is twelve months from the date hereof.
The issuance of the Options is subject to the approval of the TSX Venture Exchange. If the issuance of the Options is approved by the TSX Venture Exchange, the Options will be subject to a minimum hold period of 4 months and one day in accordance with applicable securities laws.
About Delta 9 Cannabis Inc.
Delta 9's wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical marijuana pursuant to the Access to Cannabis for Medical Purposes Regulations and operates an approximately 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9's shares trade on the TSX Venture Exchange under the symbol "NINE".
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Delta 9 Cannabis Inc.
For further information: Gary Symons, Director of Communication, Delta 9 Cannabis Inc., email@example.com, 250.300.9352